Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
DOD - Department of Defense
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
A Druggable Epigenetic Vulnerability Pathway in p53-deficient Hepatocellular Carcinoma
A Novel Therapeutic Approach for Treating WNT-Driven Hepatocellular Carcinoma
A Targeted Mitochondrial Luminoptogenetic Gene Therapy to Treat Triple Negative Breast Cancer
A Targeted Mitochondrial Luminoptogenetic Gene Therapy to Treat Triple Negative Breast Cancer
Assessing Neuroinflammation in Gulf War Illness with Whole-Brain Magnetic Resonance Spectroscopy
Boosting the Systemic and in Situ CD4+ T-Cell Responses to Malignant Glioma by Oncolytic HSV Virotherapy
Clinical Trial Award - Selumentinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Young Children with Neurofibromatosis Type 1 (NF1)
Collapsing the Tumor-Supportive Immune Portfolio of Breast Cancer to Achieve Durable Reduction of Metastasis
DNA Damage as a Predictive Biomarker for Immunotherapy Response in Ovarian Cancer
Development of a Gut Microbiome Based Prognostic Signature Predicting Risk of Hepatocellular Cancer Recurrence After Ablative Therapies
Dual PET/Fluorescence Imaging of Glioma with an MMP-14 Activabable Peptide Probe
Effects of ITGAM Genetic Variation on Mac-1 Mediated Functions of B Cells
Elevated Uracil Glycosylase Coupled to Reduced Base Excision Repair Promotes AA PCa Progression
Evaluation Of A Novel Hemostatic Agent In Junctional Trauma
Evaluation of NADPH Oxidase 1/4 Inhibition as a Novel Therapeutic Strategy Against Chronic Pancreatitis
Evaluation of Pirfenidone as a Therapy in Patients with Predicted Moderate to Severe Acute Pancreatitis
Glycocalyx Mechanoregulation of Anglopoietln-2 and Post-Traumatic Lung Injury
Gut Microbiome as a Predictor of Response to Chemotherapy in Metastatic Colorectal Cancer
IPA - Robert Meakin
IPA Robert Meakin
Immersive Virtual Walking as Treatment for Neuropathic Pain in Spinal Cord Injury: Examing Treatment Efficacy and Cortical Mechanisms
Improving Immune Response in Ovarian Cancer by Modulating the Wnt Pathway
Interactions of Gut Microbiome, Genetic Susceptibility and Environmental Factors in Parkinson's Disease
Interactions of Gut Microbiome, Genetic Susceptibility and Environmental Factors in Parkinson's Disease
Investigating the Expression, Role and Targeting of Collagen Modifying Prolyl 4-hydroxylase P4HA1 in Prostate Cancer Progression and Metastasis
Meaningful Changes in Fitness, Functional Independence, and Transfer Independence ss Defined by Individuals Living with Spinal Cord Injury
Oncobioenergetics of Breast Carcinogenesis
Overcoming PAAP Inhibitor Resistance of BACA-Deficient Ovarian Cancers
PAI-1 and Lung Fibrosis: Mechanisms and Therapeutics
PAI-1 and Lung Fibrosis: Mechanisms and Therapeutics
Part B - Surviving Blood Loss: First in Human Studies to Assess Safety and Physiological Effects of Synthetic Ethinyl Estradiol-3-Sulfate (EE·3·SO4) in Healthy Subjects, Both Euvolemic and Following 10-20% Iatrogenic Blood Loss
Pharmacological Management of Ultraviolet Radiation Induced Skin Cancer
Quantitative CT Biomarkers to Predict Metastatic RCC Response to Anti-Angiogenic Therapy
Role of Exostosin-1 in Regulating Hemorrhage-Induced Microvascular Dysfunction and Lung Injury
Sculpting Anti-tumor Immunity as an Approach to Treat Metastatic Breast Cancer
Skin Grafting From ‘9-Gene’ Genetically Engineered Pigs in the Treatment of Burns: An Experimental Study in Monkeys.
Skin Grafting from 9-Gene Genetically Engineered Pigs in the Treatment of Burns: An Experimental Study in Monkeys
Skin Grafting from 9-Gene Genetically Engineered Pigs in the Treatment of Burns: An Experimental Study in Monkeys
Targeting Homology-Directed Recombinational Repair (HDR) of Chromosomal Breaks to Sensitize Prostate Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
Targeting The CD24 Signaling for Lethal Metastatic Prostate Cancer Therapy
The Neurofibromatosis Clinical Trials Consortium
Therapeutic Recovery of Immune and Lung Tissue Bioenergetic Homeostasis in Sepsis-Induced Immunosuppression
Using Early Time-Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults with Type 2 Diabetes